These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20727390)

  • 1. Enhanced oral bioavailability of docetaxel in rats by four consecutive days of pre-treatment with curcumin.
    Yan YD; Kim DH; Sung JH; Yong CS; Choi HG
    Int J Pharm; 2010 Oct; 399(1-2):116-20. PubMed ID: 20727390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tesmilifene, a substrate of CYP3A and an inhibitor of P-glycoprotein, on the pharmacokinetics of intravenous and oral docetaxel in rats.
    Choi YH; Suh JH; Lee JH; Cho IH; Lee MG
    J Pharm Pharmacol; 2010 Aug; 62(8):1084-8. PubMed ID: 20663044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of both cytochrome P450 3A and P-glycoprotein dramatically increases docetaxel oral bioavailability and risk of intestinal toxicity.
    van Waterschoot RA; Lagas JS; Wagenaar E; van der Kruijssen CM; van Herwaarden AE; Song JY; Rooswinkel RW; van Tellingen O; Rosing H; Beijnen JH; Schinkel AH
    Cancer Res; 2009 Dec; 69(23):8996-9002. PubMed ID: 19920203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats.
    Zhang W; Tan TM; Lim LY
    Drug Metab Dispos; 2007 Jan; 35(1):110-5. PubMed ID: 17050652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of curcumin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen, in rats: possible role of CYP3A4 and P-glycoprotein inhibition by curcumin.
    Cho YA; Lee W; Choi JS
    Pharmazie; 2012 Feb; 67(2):124-30. PubMed ID: 22512082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High plasma levels and effective lymphatic uptake of docetaxel in an orally available nanotransporter formulation.
    Nassar T; Attili-Qadri S; Harush-Frenkel O; Farber S; Lecht S; Lazarovici P; Benita S
    Cancer Res; 2011 Apr; 71(8):3018-28. PubMed ID: 21363913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dose and dosage interval on the oral bioavailability of docetaxel in combination with a curcumin self-emulsifying drug delivery system (SEDDS).
    Yan YD; Marasini N; Choi YK; Kim JO; Woo JS; Yong CS; Choi HG
    Eur J Drug Metab Pharmacokinet; 2012 Sep; 37(3):217-24. PubMed ID: 22201019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetic study of paclitaxel and docetaxel in streptozotocin-induced diabetic rats.
    Lee JH; Lee A; Oh JH; Lee YJ
    Biopharm Drug Dispos; 2012 Nov; 33(8):474-86. PubMed ID: 22936118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats.
    Shin SC; Choi JS
    Anticancer Drugs; 2009 Aug; 20(7):584-8. PubMed ID: 19491656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of morin on the pharmacokinetics of docetaxel in rats with 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumors.
    Yang SH; Lee JH; Lee DY; Lee MG; Lyuk KC; Kim SH
    Arch Pharm Res; 2011 Oct; 34(10):1729-34. PubMed ID: 22076773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral curcumin on the pharmacokinetics of intravenous and oral etoposide in rats: possible role of intestinal CYP3A and P-gp inhibition by curcumin.
    Lee CK; Ki SH; Choi JS
    Biopharm Drug Dispos; 2011 May; 32(4):245-51. PubMed ID: 21506134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats.
    Li C; Li X; Choi JS
    Arch Pharm Res; 2009 Jan; 32(1):133-8. PubMed ID: 19183886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats.
    Shin SC; Choi JS; Li X
    Int J Pharm; 2006 Apr; 313(1-2):144-9. PubMed ID: 16516418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of experimental hyperlipidaemia on the pharmacokinetics of docetaxel in rats.
    Lee JH; Oh JH; Lee YJ
    Xenobiotica; 2011 Sep; 41(9):797-804. PubMed ID: 21561320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability and tissular distribution of docetaxel, a P-glycoprotein substrate, are modified by interferon-alpha in rats.
    Ben Reguiga M; Bonhomme-Faivre L; Farinotti R
    J Pharm Pharmacol; 2007 Mar; 59(3):401-8. PubMed ID: 17331344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Danshen extract does not alter pharmacokinetics of docetaxel and clopidogrel, reflecting its negligible potential in P-glycoprotein- and cytochrome P4503A-mediated herb-drug interactions.
    Lee JH; Shin YJ; Kim HJ; Oh JH; Jang YP; Lee YJ
    Int J Pharm; 2011 May; 410(1-2):68-74. PubMed ID: 21421030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cysteine on the pharmacokinetics of docetaxel in rats with protein-calorie malnutrition.
    Choi YH; Yoon I; Kim YG; Lee MG
    Xenobiotica; 2012 May; 42(5):442-55. PubMed ID: 22067009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ketoconazole on the intestinal metabolism, transport and oral bioavailability of K02, a novel vinylsulfone peptidomimetic cysteine protease inhibitor and a P450 3A, P-glycoprotein dual substrate, in male Sprague-Dawley rats.
    Zhang Y; Hsieh Y; Izumi T; Lin ET; Benet LZ
    J Pharmacol Exp Ther; 1998 Oct; 287(1):246-52. PubMed ID: 9765344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of baicalein on the pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats: possible role of cytochrome P450 3A4 and P-glycoprotein inhibition by baicalein.
    Li C; Kim M; Choi H; Choi J
    Arch Pharm Res; 2011 Nov; 34(11):1965-72. PubMed ID: 22139696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual and combined roles of CYP3A, P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) in the pharmacokinetics of docetaxel.
    van Waterschoot RA; Lagas JS; Wagenaar E; Rosing H; Beijnen JH; Schinkel AH
    Int J Cancer; 2010 Dec; 127(12):2959-64. PubMed ID: 21351274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.